Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025 -15751.1% Operating margin3 1227.6% Revenue growth, 20253 Where the money goes Where each dollar of revenue went, fiscal 2025 Other costs
Other costs 93¢ $3.8M Income tax 7¢ $298.0K Out of $4.1M in revenue.3
Financial statements
Income statement Balance sheet Cash flow
Annual Quarterly
Revenue3 $4.1M in 2025+1228% since 2024 0 $2.0M $4.0M $6.0M 2024: $308.0K $308.0K 2024 2025: $4.1M $4.1M 2025 +1228% Operating income3 -$644.1M in 2025+527% since 2024 -$800.0M -$600.0M -$400.0M -$200.0M 0 2024: -$102.7M -$102.7M 2024 2025: -$644.1M -$644.1M 2025 +527% Net income3 -$660.0M in 2025+342% since 2024 -$800.0M -$600.0M -$400.0M -$200.0M 0 2024: -$149.3M -$149.3M 2024 2025: -$660.0M -$660.0M 2025 +342% Revenue4 5 $1.7M in Q2 FY2026+10% since Q1 FY2025 0 $500.0K $1.0M $1.5M $2.0M Q1 FY2025: $1.6M $1.6M Q1 FY2025 Q2 FY2025: $719.0K $719.0K Q2 FY2025 −54% Q1 FY2026: $954.0K $954.0K Q1 FY2026 +33% Q2 FY2026: $1.7M $1.7M Q2 FY2026 +79% Operating income4 5 -$44.1M in Q2 FY2026+117% since Q1 FY2025 -$60.0M -$40.0M -$20.0M 0 Q1 FY2025: -$20.4M -$20.4M Q1 FY2025 Q2 FY2025: -$25.3M -$25.3M Q2 FY2025 +24% Q1 FY2026: -$30.9M -$30.9M Q1 FY2026 +22% Q2 FY2026: -$44.1M -$44.1M Q2 FY2026 +43% Net income4 5 -$32.5M in Q2 FY2026+23% since Q1 FY2025 -$40.0M -$30.0M -$20.0M -$10.0M 0 Q1 FY2025: -$26.4M -$26.4M Q1 FY2025 Q2 FY2025: -$27.7M -$27.7M Q2 FY2025 +5% Q1 FY2026: -$29.8M -$29.8M Q1 FY2026 +7% Q2 FY2026: -$32.5M -$32.5M Q2 FY2026 +9% Fiscal year 2023 2024 2025 Revenue $308.0K3 $4.1M3 Research and development $900.0K3 Operating income -$102.7M3 -$644.1M3 Income tax -$356.0K3 $298.0K3 Net income -$149.3M3 -$660.0M3 Earnings per share -$0.933 -$2.913 Earnings per share (diluted) -$0.933 -$2.913
Total assets3 $292.7M in 2025+84% since 2024 0 $100.0M $200.0M $300.0M 2024: $159.4M $159.4M 2024 2025: $292.7M $292.7M 2025 +84% Total liabilities3 $70.7M in 2025+65% since 2024 0 $20.0M $40.0M $60.0M $80.0M 2024: $42.8M $42.8M 2024 2025: $70.7M $70.7M 2025 +65% Shareholders’ equity3 $221.9M in 2025+91% since 2024 0 $100.0M $200.0M $300.0M 2024: $116.3M $116.3M 2024 2025: $221.9M $221.9M 2025 +91% Cash3 $85.3M in 2025+89% since 2023 0 $25.0M $50.0M $75.0M $100.0M 2023: $45.0M $45.0M 2023 2024: $17.5M $17.5M 2024 −61% 2025: $85.3M $85.3M 2025 +387% Long-term debt3 $0 in 20250 $5.0M $10.0M $15.0M 2024: $14.1M $14.1M 2024 2025: $0 $0 2025 Total assets4 5 $264.8M in Q2 FY2026−10% since Q1 FY2025 0 $100.0M $200.0M $300.0M Q1 FY2025: $292.7M $292.7M Q1 FY2025 Q2 FY2025: $292.7M $292.7M Q2 FY2025 +0% Q1 FY2026: $264.9M $264.9M Q1 FY2026 −10% Q2 FY2026: $264.8M $264.8M Q2 FY2026 −0% Total liabilities4 5 $88.4M in Q2 FY2026+25% since Q1 FY2025 0 $25.0M $50.0M $75.0M $100.0M Q1 FY2025: $70.7M $70.7M Q1 FY2025 Q2 FY2025: $70.7M $70.7M Q2 FY2025 +0% Q1 FY2026: $66.1M $66.1M Q1 FY2026 −7% Q2 FY2026: $88.4M $88.4M Q2 FY2026 +34% Shareholders’ equity4 5 $176.4M in Q2 FY2026−21% since Q1 FY2025 0 $100.0M $200.0M $300.0M Q1 FY2025: $221.9M $221.9M Q1 FY2025 Q2 FY2025: $221.9M $221.9M Q2 FY2025 +0% Q1 FY2026: $198.7M $198.7M Q1 FY2026 −10% Q2 FY2026: $176.4M $176.4M Q2 FY2026 −11% Cash4 5 $168.8M in Q2 FY2026+190% since Q1 FY2025 0 $50.0M $100.0M $150.0M $200.0M Q1 FY2025: $58.3M $58.3M Q1 FY2025 Q2 FY2025: $61.9M $61.9M Q2 FY2025 +6% Q1 FY2025: $85.3M $85.3M Q1 FY2025 +38% Q2 FY2025: $85.3M $85.3M Q2 FY2025 +0% Q1 FY2026: $43.1M $43.1M Q1 FY2026 −49% Q2 FY2026: $168.8M $168.8M Q2 FY2026 +292% Fiscal year 2023 2024 2025 Cash $45.0M3 $17.5M3 $85.3M3 Current assets $80.1M3 $275.7M3 Total assets $159.4M3 $292.7M3 Current liabilities $25.0M3 $23.5M3 Long-term debt $14.1M3 $03 Total liabilities $42.8M3 $70.7M3 Shareholders’ equity $116.3M3 $221.9M3 Shares outstanding 168.0M shares3 363.3M shares3
Cash from operations3 -$102.7M in 2025+25% since 2024 -$150.0M -$100.0M -$50.0M 0 2024: -$82.4M -$82.4M 2024 2025: -$102.7M -$102.7M 2025 +25% Capital spending3 $901.0K in 2025+14917% since 2024 0 $250.0K $500.0K $750.0K $1.0M 2024: $6.0K $6.0K 2024 2025: $901.0K $901.0K 2025 +14917% Free cash flow3 -$103.6M in 2025+26% since 2024 -$150.0M -$100.0M -$50.0M 0 2024: -$82.4M -$82.4M 2024 2025: -$103.6M -$103.6M 2025 +26% Cash from operations4 -$21.1M in Q1 FY2026+18% since Q1 FY2025 -$30.0M -$20.0M -$10.0M 0 Q1 FY2025: -$17.8M -$17.8M Q1 FY2025 Q1 FY2026: -$21.1M -$21.1M Q1 FY2026 +18% Capital spending4 $0 in Q1 FY20260 $100.0K $200.0K $300.0K Q1 FY2025: $268.0K $268.0K Q1 FY2025 Q1 FY2026: $0 $0 Q1 FY2026 Free cash flow4 -$21.1M in Q1 FY2026+16% since Q1 FY2025 -$30.0M -$20.0M -$10.0M 0 Q1 FY2025: -$18.1M -$18.1M Q1 FY2025 Q1 FY2026: -$21.1M -$21.1M Q1 FY2026 +16% Fiscal year 2023 2024 2025 Cash from operations -$82.4M3 -$102.7M3 Capital spending $6.0K3 $901.0K3 Free cash flow -$82.4M -$103.6M
Compare AtaiBeckley Inc. with another company
Former names
atai Life Sciences Luxembourg S.A. Aug 13, 2025 to Dec 31, 20252
Recent filings
Sep 11, 2026 8-K Sep 11, 2026 4 Sep 11, 2026 4 Sep 11, 2026 4 Sep 11, 2026 4 Sep 11, 2026 4 Sep 11, 2026 4 Sep 11, 2026 4 Sep 11, 2026 4 Sep 11, 2026 4 Sep 11, 2026 4 Sep 11, 2026 4 Sep 11, 2026 4 Sep 11, 2026 4 Sep 11, 2026 4 Every filing from the last three years, summarized . The full record is on SEC EDGAR.1
